Mirum Pharmaceuticals (MIRM) Downgraded by Zacks Investment Research to Sell

Mirum Pharmaceuticals} stock has undergone multiple analysts rating changes in the recent past.  Mirum Pharmaceuticals Downgraded by Zacks Investment Research on 10/15/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Mirum Pharmaceuticals (MIRM) Downgraded by Zacks Investment Research to Sell

Factors Likely to Have Influenced Earnings Results NASDAQ:NARI, NASDAQ:MIRM, NASDAQ:CREX, NASDAQ:TACO

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Factors Likely to Have Influenced Earnings Results NASDAQ:NARI, NASDAQ:MIRM, NASDAQ:CREX, NASDAQ:TACO

Reports First Quarter 2020 Results Mirum Pharmaceuticals (NASDAQ:MIRM)

Earnings results for Mirum Pharmaceuticals , Analyst Opinion on Mirum Pharmaceuticals , Earnings and Valuation of (NASDAQ:MIRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Reports First Quarter 2020 Results Mirum Pharmaceuticals (NASDAQ:MIRM)

Factors Likely to Have Influenced Earnings Results NASDAQ:NARI, NASDAQ:MIRM, NASDAQ:CREX, NASDAQ:TACO

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Factors Likely to Have Influenced Earnings Results NASDAQ:NARI, NASDAQ:MIRM, NASDAQ:CREX, NASDAQ:TACO

Will earnings report, end it’s winning streak? Mirum Pharmaceuticals (NASDAQ:MIRM)

Earnings results for Mirum Pharmaceuticals , Analyst Opinion on Mirum Pharmaceuticals , Earnings and Valuation of (NASDAQ:MIRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Will earnings report, end it’s winning streak? Mirum Pharmaceuticals (NASDAQ:MIRM)

Analysts Estimate Report : What to Look Out for Mirum Pharmaceuticals (NASDAQ:MIRM)

Earnings results for Mirum Pharmaceuticals , Analyst Opinion on Mirum Pharmaceuticals , Earnings and Valuation of (NASDAQ:MIRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Analysts Estimate Report : What to Look Out for Mirum Pharmaceuticals (NASDAQ:MIRM)